iShares iBonds Dec 2035 Term Corporate ETF (IBCA) Stock Overview
Explore iShares iBonds Dec 2035 Term Corporate ETF’s financial performance, market position, analyst ratings, and future outlook.
iShares iBonds Dec 2035 Term Corporate ETF (IBCA)
Key Financials
Key Financials
Market Cap
93M
P/E Ratio
N/A
EPS (TTM)
N/A
ROE
0.00%
IBCA Stock Analysis & Investment Overview (AMEX)
Our AI-powered analysis of iShares iBonds Dec 2035 Term Corporate ETF (AMEX: IBCA) gives investors deep insight into how the stock performs on the AMEX exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, iShares iBonds Dec 2035 Term Corporate ETF's AMEX-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of IBCA on the AMEX shows an RSI of 32.54, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $24.60 for the AMEX listing.
Key metrics behind iShares iBonds Dec 2035 Term Corporate ETF's AMEX-traded stock include a P/E ratio of N/A and a market capitalization of 93M. Combined with our AI analysis, these give both institutional and retail investors a clear view of IBCA on the AMEX.